Citadel Advisors LLC 13D and 13G filings for OnKure Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:53 pm Sale | 2025-12-31 | 13G | OnKure Therapeutics, Inc. OKUR | Citadel Advisors LLC | 223,125 1.700% | -1,048,246 (-82.45%) | Filing |
| 2024-10-11 5:24 pm Purchase | 2024-10-04 | 13G | OnKure Therapeutics, Inc. OKUR | Citadel Advisors LLC | 1,271,371 9.900% | 1,271,371 (New Position) | Filing |